TPG-backed Adare Pharmaceuticals buys Orbis Biosciences

Adare Pharmaceuticals Inc, which is backed by TPG Capital, has acquired Lenexa, Kansas-based Orbis Biosciences, a pharmaceutical manufacturing technology company.

To view this content, you need to sign in.


You should only be asked to sign in once. Not the case? Click here


Register now to access this content and more for free.

Share this